Ivermectin-d2

• Description:

  Ivermectin-d2 is deuterium labeled Ivermectin[1].

• UNSPSC:

  12352005

• Target:

  Isotope-Labeled Compounds

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others

• Purity:

  97.63

• Smiles:

  C/C ([C@H] ([C@@H] (C) /C=C/C=C1CO[C@@]2 ([H]) [C@@]\1 ([C@@] (C=C (C) [C@H]2O) 3[H]) O) O[C@@]4 ([H]) C[C@H] (OC) [C@@H] (O[C@@]5 ([H]) C[C@H] (OC) [C@@H] (O) [C@H] (C) O5) [C@H] (C) O4) =C\C[C@]6 ([H]) C[C@@H] (C[C@@]7 (O[C@] ([C@@H] (C) C ([2H]) [C@H]7[2H]) ([H]) [C@@] (C) (CC) [H]) O6) OC3=O

• Molecular Formula:

  C48H72D2O14

• Molecular Weight:

  877.11

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported